Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Arai, Nana"" wg kryterium: Autor


Wyświetlanie 1-83 z 83
Tytuł :
Characteristics and predictors of post-transplant-associated hemophagocytic lymphohistiocytosis in adults
Autorzy :
Hattori, Norimichi
Sato, Misuzu
Uesugi, Yuka
Nakata, Ayaka
Sasaki, Yohei
Shimada, Shotaro
Watanuki, Megumi
Fujiwara, Shun
Kawaguchi, Yukiko
Arai, Nana
Uto, Yui
Matsui, Tomoharu
Yanagisawa, Kouji
Tahara, Sachiko
Koeffler, H Phillip
Iezumi, Keiichi
Nakamaki, Tsuyoshi
Pokaż więcej
Źródło :
International Journal of Hematology. :1-10
Czasopismo naukowe
Tytuł :
Elevated C-reactive protein level is associated with poor prognosis in follicular lymphoma patients undergoing rituximab-containing chemotherapy
Autorzy :
Kawaguchi, Yukiko
Saito, Bungo
Nakata, Ayaka
Matsui, Tomoharu
Sasaki, Yohei
Shimada, Shotaro
Abe, Maasa
Watanuki, Megumi
Baba, Yuta
Murai, So
Arai, Nana
Fujiwara, Shun
Kabasawa, Nobuyuki
Tsukamoto, Hiroyuki
Uto, Yui
Yanagisawa, Kouji
Hattori, Norimichi
Harada, Hiroshi
Nakamaki, Tsuyoshi
Pokaż więcej
Źródło :
International Journal of Hematology. 112(3):341-348
Czasopismo naukowe
Tytuł :
Comparative Study of Tacrolimus and Short-Term Methotrexate: 2-Day versus 3-Day Methotrexate as Graft-versus-Host-Disease Prophylaxis after Umbilical Cord Blood Transplantation in Adults
Autorzy :
Hattori, Norimichi
Saito, Bungo
Matsui, Tomoharu
Nakata, Ayaka
Sasaki, Yohei
Shimada, Shotaro
Murai, So
Abe, Maasa
Baba, Yuta
Watanuki, Megumi
Fujiwara, Shun
Kawaguchi, Yukiko
Arai, Nana
Kabasawa, Nobuyuki
Tsukamoto, Hiroyuki
Uto, Yui
Yanagisawa, Kouji
Harada, Hiroshi
Nakamaki, Tsuyoshi
Pokaż więcej
Źródło :
In Biology of Blood and Marrow Transplantation February 2020 26(2):367-372
Czasopismo naukowe
Tytuł :
Refined Disease Risk Index for Hematological Malignancies, Including Rare Disorders, After Allogeneic Stem Cell Transplantation
Autorzy :
Fujiwara, Shun
Hattori, Norimichi
Matsui, Tomoharu
Nakata, Ayaka
Sasaki, Yohei
Shimada, Shotaro
Murai, So
Abe, Maasa
Baba, Yuta
Watanuki, Megumi
Kawaguchi, Yukiko
Arai, Nana
Kabasawa, Nobuyuki
Tsukamoto, Hiroyuki
Uto, Yui
Yanagisawa, Kouji
Harada, Hiroshi
Nakamaki, Tsuyoshi
Pokaż więcej
Źródło :
In Transplantation Proceedings December 2019 51(10):3437-3443
Czasopismo naukowe
Tytuł :
Monitoring TIGIT/DNAM-1 and PVR/PVRL2 Immune Checkpoint Expression Levels in Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
Autorzy :
Hattori, Norimichi
Kawaguchi, Yukiko
Sasaki, Yohei
Shimada, Shotaro
Murai, So
Abe, Maasa
Baba, Yuta
Watanuki, Megumi
Fujiwara, Shun
Arai, Nana
Kabasawa, Nobuyuki
Tsukamoto, Hiroyuki
Uto, Yui
Yanagisawa, Kouji
Saito, Bungo
Harada, Hiroshi
Nakamaki, Tsuyoshi
Pokaż więcej
Źródło :
In Biology of Blood and Marrow Transplantation May 2019 25(5):861-867
Czasopismo naukowe
Tytuł :
Impact of CD123 expression, analyzed by immunohistochemistry, on clinical outcomes in patients with acute myeloid leukemia
Autorzy :
Arai, NanaAff1, Aff2
Homma, Mayumi
Abe, Maasa
Baba, Yuta
Murai, So
Watanuki, Megumi
Kawaguchi, Yukiko
Fujiwara, Shun
Kabasawa, Nobuyuki
Tsukamoto, Hiroyuki
Uto, Yui
Ariizumi, Hirotsugu
Yanagisawa, Kouji
Hattori, Norimichi
Saito, Bungo
Shiozawa, Eisuke
Harada, Hiroshi
Yamochi-Onizuka, Toshiko
Nakamaki, Tsuyoshi
Takimoto, Masafumi
Pokaż więcej
Źródło :
International Journal of Hematology. 109(5):539-544
Czasopismo naukowe
Tytuł :
Status of Natural Killer Cell Recovery in Day 21 Bone Marrow after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome
Autorzy :
Hattori, Norimichi
Saito, Bungo
Sasaki, Yohei
Shimada, Shotaro
Murai, So
Abe, Maasa
Baba, Yuta
Watanuki, Megumi
Fujiwara, Shun
Kawaguchi, Yukiko
Arai, Nana
Kabasawa, Nobuyuki
Tsukamoto, Hiroyuki
Uto, Yui
Ariizumi, Hirotsugu
Yanagisawa, Kouji
Harada, Hiroshi
Nakamaki, Tsuyoshi
Pokaż więcej
Źródło :
In Biology of Blood and Marrow Transplantation September 2018 24(9):1841-1847
Czasopismo naukowe
Tytuł :
Efficacy of palonosetron to prevent delayed nausea and vomiting in non-Hodgkin’s lymphoma patients undergoing repeated cycles of the CHOP regimen
Autorzy :
Saito, Bungo
Nakashima, Hidetoshi
Abe, Maasa
Murai, So
Baba, Yuta
Arai, Nana
Kawaguchi, Yukiko
Fujiwara, Shun
Kabasawa, Nobuyuki
Tsukamoto, Hiroyuki
Uto, Yui
Ariizumi, Hirotsugu
Yanagisawa, Kouji
Hattori, Norimichi
Harada, Hiroshi
Nakamaki, Tsuyoshi
Pokaż więcej
Źródło :
Supportive Care in Cancer. 26(1):269-274
Czasopismo naukowe
Tytuł :
Corrigendum to ‘Comparative Study of Tacrolimus and Short-Term Methotrexate: 2-Day versus 3-Day Methotrexate as Graft-versus-Host-Disease Prophylaxis after Umbilical Cord Blood Transplantation in Adults’ [Biology of Blood and Marrow Transplantation 26/2 (2020) 367-372]
Autorzy :
Hattori, Norimichi
Saito, Bungo
Matsui, Tomoharu
Nakata, Ayaka
Sasaki, Yohei
Shimada, Shotaro
Murai, So
Abe, Maasa
Baba, Yuta
Watanuki, Megumi
Fujiwara, Shun
Kawaguchi, Yukiko
Arai, Nana
Kabasawa, Nobuyuki
Tsukamoto, Hiroyuki
Uto, Yui
Yanagisawa, Kouji
Harada, Hiroshi
Nakamaki, Tsuyoshi
Pokaż więcej
Źródło :
In Biology of Blood and Marrow Transplantation
Czasopismo naukowe
Tytuł :
Solvation Structure of Li Li Isotopic Substitution Methods.
Autorzy :
Kameda Y; Department of Material and Biological Chemistry, Faculty of Science, Yamagata University, 1-4-12 Kojirakawa-machi, Yamagata, Yamagata 990-8560, Japan.
Saito S; Department of Material and Biological Chemistry, Faculty of Science, Yamagata University, 1-4-12 Kojirakawa-machi, Yamagata, Yamagata 990-8560, Japan.
Saji A; Department of Material and Biological Chemistry, Faculty of Science, Yamagata University, 1-4-12 Kojirakawa-machi, Yamagata, Yamagata 990-8560, Japan.
Amo Y; Department of Material and Biological Chemistry, Faculty of Science, Yamagata University, 1-4-12 Kojirakawa-machi, Yamagata, Yamagata 990-8560, Japan.
Usuki T; Department of Material and Biological Chemistry, Faculty of Science, Yamagata University, 1-4-12 Kojirakawa-machi, Yamagata, Yamagata 990-8560, Japan.
Watanabe H; Graduate School of Science and Technology, Niigata University, 8050 Ikarashi, 2-no-cho, Nishi-ku, Niigata City 950-2181, Japan.
Arai N; Graduate School of Science and Technology, Niigata University, 8050 Ikarashi, 2-no-cho, Nishi-ku, Niigata City 950-2181, Japan.
Umebayashi Y; Graduate School of Science and Technology, Niigata University, 8050 Ikarashi, 2-no-cho, Nishi-ku, Niigata City 950-2181, Japan.
Fujii K; Graduate School of Sciences and Technology for Innovation, Yamaguchi University, 2-16-1 Tokiwadai, Ube, Yamaguchi 755-8611, Japan.
Ueno K; Department of Chemistry and Biotechnology, Yokohama National University, 79-5 Tokiwadai, Hodogaya-ku, Yokohama 240-8501, Japan.
Ikeda K; Institute of Materials Structure Science, High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-0801, Japan.
Otomo T; Institute of Materials Structure Science, High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-0801, Japan.
Pokaż więcej
Źródło :
The journal of physical chemistry. B [J Phys Chem B] 2020 Nov 19; Vol. 124 (46), pp. 10456-10464. Date of Electronic Publication: 2020 Nov 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Corrigendum to 'Comparative Study of Tacrolimus and Short-Term Methotrexate: 2-Day versus 3-Day Methotrexate as Graft-versus-Host-Disease Prophylaxis after Umbilical Cord Blood Transplantation in Adults' [Biology of Blood and Marrow Transplantation 26/2 (2020) 367-372].
Autorzy :
Hattori N; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan. Electronic address: .
Saito B; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Matsui T; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Nakata A; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Sasaki Y; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Shimada S; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Murai S; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Abe M; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Baba Y; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Watanuki M; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Fujiwara S; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Kawaguchi Y; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Arai N; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Kabasawa N; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Tsukamoto H; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Uto Y; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Yanagisawa K; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Harada H; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Nakamaki T; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Mar 12. Date of Electronic Publication: 2020 Mar 12.
Typ publikacji :
Published Erratum
Tytuł :
[Development of cardiac tamponade and emergence of arrhythmia during chemotherapy for diffuse large B-cell lymphoma].
Autorzy :
Baba Y; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Saito B; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Shimada S; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Sasaki Y; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Murai S; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Abe M; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Fujiwara S; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Arai N; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Kawaguchi Y; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Kabasawa N; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Tsukamoto H; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Uto Y; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Yanagisawa K; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Hattori N; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Harada H; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Nakamaki T; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Pokaż więcej
Źródło :
[Rinsho ketsueki] The Japanese journal of clinical hematology [Rinsho Ketsueki] 2019; Vol. 60 (6), pp. 577-581.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Cardiac Tamponade/*chemically induced
Heart Neoplasms/*complications
Lymphoma, Large B-Cell, Diffuse/*complications
Aged ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Arrhythmias, Cardiac ; Heart Neoplasms/drug therapy ; Humans ; Lymphoma, Large B-Cell, Diffuse/drug therapy ; Male ; Pericardial Effusion
Czasopismo naukowe
Tytuł :
[Syndrome of inappropriate secretion of antidiuretic hormone in multiple myeloma patients treated with bortezomib, lenalidomide, and dexamethasone combination therapy].
Autorzy :
Baba Y; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Harada H; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Shimada S; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Sasaki Y; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Murai S; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Abe M; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Fujiwara S; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Arai N; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Kawaguchi Y; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Kabasawa N; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Tsukamoto H; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Uto Y; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Ariizumi H; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Yanagisawa K; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Hattori N; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Saito B; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Nakamaki T; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Pokaż więcej
Źródło :
[Rinsho ketsueki] The Japanese journal of clinical hematology [Rinsho Ketsueki] 2018; Vol. 59 (11), pp. 2423-2427.
Typ publikacji :
Journal Article
MeSH Terms :
Inappropriate ADH Syndrome*/chemically induced
Multiple Myeloma*/drug therapy
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bortezomib/administration & dosage ; Bortezomib/adverse effects ; Dexamethasone/administration & dosage ; Dexamethasone/adverse effects ; Female ; Humans ; Lenalidomide/administration & dosage ; Lenalidomide/adverse effects
Czasopismo naukowe
Tytuł :
Local Structure of Li Li Isotopic Substitution Methods.
Autorzy :
Maeda S; Department of Material and Biological Chemistry, Faculty of Science, Yamagata University , Yamagata 990-8560, Japan.
Kameda Y; Department of Material and Biological Chemistry, Faculty of Science, Yamagata University , Yamagata 990-8560, Japan.
Amo Y; Department of Material and Biological Chemistry, Faculty of Science, Yamagata University , Yamagata 990-8560, Japan.
Usuki T; Department of Material and Biological Chemistry, Faculty of Science, Yamagata University , Yamagata 990-8560, Japan.
Ikeda K; Institute of Material Structure Science, KEK , Tsukuba, Ibaraki 305-0801, Japan.
Otomo T; Institute of Material Structure Science, KEK , Tsukuba, Ibaraki 305-0801, Japan.
Yanagisawa M; Department of Environmental Chemistry and Chemical Engineering, School of Advanced Engineering, Kogakuin University , Tokyo 192-0015, Japan.
Seki S; Department of Environmental Chemistry and Chemical Engineering, School of Advanced Engineering, Kogakuin University , Tokyo 192-0015, Japan.
Arai N; Graduate School of Science and Technology, Niigata University , 8050 Ikarashi, 2-no-cho, Nishi-ku, Niigata City 950-2181, Japan.
Watanabe H; Graduate School of Science and Technology, Niigata University , 8050 Ikarashi, 2-no-cho, Nishi-ku, Niigata City 950-2181, Japan.
Umebayashi Y; Graduate School of Science and Technology, Niigata University , 8050 Ikarashi, 2-no-cho, Nishi-ku, Niigata City 950-2181, Japan.
Pokaż więcej
Źródło :
The journal of physical chemistry. B [J Phys Chem B] 2017 Dec 07; Vol. 121 (48), pp. 10979-10987. Date of Electronic Publication: 2017 Nov 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
CD200 Expression on Plasma Cell Myeloma Cells is Associated with the Efficacies of Bortezomib, Lenalidomide and Thalidomide.
Autorzy :
Tazawa S; Department of Pathology and Laboratory Medicine, Showa University School of Medicine.
Shiozawa E
Homma M
Arai N
Kabasawa N
Kawaguchi Y
Fujiwara S
Okino K
Kobayashi K
Yamochi T
Tate G
Nakamaki T
Takimoto M
Pokaż więcej
Źródło :
Journal of clinical and experimental hematopathology : JCEH [J Clin Exp Hematop] 2015; Vol. 55 (3), pp. 121-6.
Typ publikacji :
Journal Article
MeSH Terms :
Antigens, CD/*metabolism
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Multiple Myeloma/*drug therapy
Multiple Myeloma/*metabolism
Adult ; Aged ; Aged, 80 and over ; Antigens, CD/genetics ; Biomarkers ; Bortezomib/administration & dosage ; Female ; Gene Expression ; Humans ; Immunohistochemistry ; Lenalidomide ; Male ; Middle Aged ; Multiple Myeloma/diagnosis ; Multiple Myeloma/mortality ; Neoplasm Staging ; Prognosis ; Survival Analysis ; Thalidomide/administration & dosage ; Thalidomide/analogs & derivatives ; Treatment Outcome
Czasopismo naukowe
    Wyświetlanie 1-83 z 83

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies